Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Cell-Type-Specific Profiling of Alternative Translation Identifies Regulated Protein Isoform Variation in the Mouse Brain.

Sapkota D, Lake AM, Yang W, Yang C, Wesseling H, Guise A, Uncu C, Dalal JS, Kraft AW, Lee JM, Sands MS, Steen JA, Dougherty JD.

Cell Rep. 2019 Jan 15;26(3):594-607.e7. doi: 10.1016/j.celrep.2018.12.077.

2.

Fetal regional brain protein signature in FASD rat model.

Davis-Anderson KL, Wesseling H, Siebert LM, Lunde-Young ER, Naik VD, Steen H, Ramadoss J.

Reprod Toxicol. 2018 Mar;76:84-92. doi: 10.1016/j.reprotox.2018.01.004. Epub 2018 Feb 1.

3.

Chemogenomic analysis reveals key role for lysine acetylation in regulating Arc stability.

Lalonde J, Reis SA, Sivakumaran S, Holland CS, Wesseling H, Sauld JF, Alural B, Zhao WN, Steen JA, Haggarty SJ.

Nat Commun. 2017 Nov 21;8(1):1659. doi: 10.1038/s41467-017-01750-7.

4.

A brain proteomic investigation of rapamycin effects in the Tsc1+/- mouse model.

Wesseling H, Elgersma Y, Bahn S.

Mol Autism. 2017 Aug 1;8:41. doi: 10.1186/s13229-017-0151-y. eCollection 2017.

5.

Evaluation of molecular brain changes associated with environmental stress in rodent models compared to human major depressive disorder: A proteomic systems approach.

Cox DA, Gottschalk MG, Stelzhammer V, Wesseling H, Cooper JD, Bahn S.

World J Biol Psychiatry. 2018;19(sup2):S63-S74. doi: 10.1080/15622975.2016.1252465. Epub 2016 Nov 25.

PMID:
27784204
6.

Proteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathology.

Cox DA, Gottschalk MG, Wesseling H, Ernst A, Cooper JD, Bahn S.

Schizophr Res. 2016 Nov;177(1-3):98-107. doi: 10.1016/j.schres.2016.06.012. Epub 2016 Jun 19.

PMID:
27335180
7.

System-based proteomic and metabonomic analysis of the Df(16)A+/- mouse identifies potential miR-185 targets and molecular pathway alterations.

Wesseling H, Xu B, Want EJ, Holmes E, Guest PC, Karayiorgou M, Gogos JA, Bahn S.

Mol Psychiatry. 2017 Mar;22(3):384-395. doi: 10.1038/mp.2016.27. Epub 2016 Mar 22.

8.

Hippocampal Proteomic and Metabonomic Abnormalities in Neurotransmission, Oxidative Stress, and Apoptotic Pathways in a Chronic Phencyclidine Rat Model.

Wesseling H, Want EJ, Guest PC, Rahmoune H, Holmes E, Bahn S.

J Proteome Res. 2015 Aug 7;14(8):3174-87. doi: 10.1021/acs.jproteome.5b00105. Epub 2015 Jun 30.

9.

Effects of olanzapine on serum protein phosphorylation patterns in patients with schizophrenia.

Jaros JA, Rahmoune H, Wesseling H, Leweke FM, Ozcan S, Guest PC, Bahn S.

Proteomics Clin Appl. 2015 Oct;9(9-10):907-16. doi: 10.1002/prca.201400148. Epub 2015 May 15.

PMID:
25821032
10.

Proteomic enrichment analysis of psychotic and affective disorders reveals common signatures in presynaptic glutamatergic signaling and energy metabolism.

Gottschalk MG, Wesseling H, Guest PC, Bahn S.

Int J Neuropsychopharmacol. 2014 Oct 31;18(2). pii: pyu019. doi: 10.1093/ijnp/pyu019.

11.

Targeted multiplexed selected reaction monitoring analysis evaluates protein expression changes of molecular risk factors for major psychiatric disorders.

Wesseling H, Gottschalk MG, Bahn S.

Int J Neuropsychopharmacol. 2014 Oct 31;18(1). pii: pyu015. doi: 10.1093/ijnp/pyu015.

12.

A targeted multiplexed proteomic investigation identifies ketamine-induced changes in immune markers in rat serum and expression changes in protein kinases/phosphatases in rat brain.

Wesseling H, Rahmoune H, Tricklebank M, Guest PC, Bahn S.

J Proteome Res. 2015 Jan 2;14(1):411-21. doi: 10.1021/pr5009493. Epub 2014 Nov 19.

PMID:
25363195
13.

Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders.

Wesseling H, Guest PC, Lee CM, Wong EH, Rahmoune H, Bahn S.

Mol Autism. 2014 Jul 4;5:38. doi: 10.1186/2040-2392-5-38. eCollection 2014.

14.

Technological advances for deciphering the complexity of psychiatric disorders: merging proteomics with cell biology.

Wesseling H, Guest PC, Lago SG, Bahn S.

Int J Neuropsychopharmacol. 2014 Aug;17(8):1327-41. doi: 10.1017/S146114571400008X. Epub 2014 Feb 14. Review.

PMID:
24524332
15.

A combined metabonomic and proteomic approach identifies frontal cortex changes in a chronic phencyclidine rat model in relation to human schizophrenia brain pathology.

Wesseling H, Chan MK, Tsang TM, Ernst A, Peters F, Guest PC, Holmes E, Bahn S.

Neuropsychopharmacology. 2013 Nov;38(12):2532-44. doi: 10.1038/npp.2013.160. Epub 2013 Jul 3.

16.

Behavioral and molecular biomarkers in translational animal models for neuropsychiatric disorders.

Sarnyai Z, Alsaif M, Bahn S, Ernst A, Guest PC, Hradetzky E, Kluge W, Stelzhammer V, Wesseling H.

Int Rev Neurobiol. 2011;101:203-38. doi: 10.1016/B978-0-12-387718-5.00008-0. Review.

PMID:
22050853
17.

The need for phosphoproteomic approaches in psychiatric research.

Martins-de-Souza D, Guest PC, Vanattou-Saifoudine N, Wesseling H, Rahmoune H, Bahn S.

J Psychiatr Res. 2011 Oct;45(10):1404-6. doi: 10.1016/j.jpsychires.2011.04.007. Epub 2011 May 26. No abstract available.

PMID:
21616503
18.

Exopolyphosphatases PPX1 and PPX2 from Corynebacterium glutamicum.

Lindner SN, Knebel S, Wesseling H, Schoberth SM, Wendisch VF.

Appl Environ Microbiol. 2009 May;75(10):3161-70. doi: 10.1128/AEM.02705-08. Epub 2009 Mar 20.

20.

Clinical and neurohumoral differences between spirapril and captopril in mild to moderate chronic congestive heart failure.

van den Broek SA, de Graeff PA, van Veldhuisen DJ, van Gilst WH, Hillege H, Wesseling H, Lie KI.

J Card Fail. 1997 Sep;3(3):165-71.

PMID:
9330124
21.

Rate-dependent effects of the class III antiarrhythmic drug almokalant on refractoriness in the pig.

Wiesfeld AC, De Langen CD, Crijns HJ, Bel KJ, Hillege HL, Wesseling H, Lie KI.

J Cardiovasc Pharmacol. 1996 Apr;27(4):594-600.

PMID:
8847879
22.

Comparative effects of diltiazem and lisinopril on left ventricular structure and filling in mild-to-moderate hypertension.

van Leeuwen JT, Smit AJ, May JF, ten Berge BS, Hamer HP, Havinga TK, Schuurman FH, van der Veru E, Lie KI, Wesseling H.

J Cardiovasc Pharmacol. 1995 Dec;26(6):983-9.

PMID:
8606538
23.

Relation between myocardial beta-adrenoceptor density and hemodynamic and neurohumoral changes in a rat model of chronic myocardial infarction: effects of ibopamine and captopril.

van Veldhuisen DJ, Brodde OE, van Gilst WH, Schulze C, Hegeman H, Anthonio RL, Scholtens E, de Graeff PA, Wesseling H, Lie KI.

Cardiovasc Res. 1995 Sep;30(3):386-93.

PMID:
7585830
24.

Vulvo-vaginal candidiasis associated with acitretin.

Sturkenboom MC, Middelbeek A, de Jong van den Berg LT, van den Berg PB, Stricker BH, Wesseling H.

J Clin Epidemiol. 1995 Aug;48(8):991-7.

PMID:
7775998
25.

The role of pharmacists in the recruitment of a cohort for postmarketing surveillance. A case study of acitretin in The Netherlands.

Sturkenboom MC, Stricker BH, de Jong-van den Berg LT, Cornel MC, Wesseling H.

Pharm World Sci. 1995 Jul 28;17(4):126-32.

PMID:
7581218
26.
27.

Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.

van den Broek SA, de Graeff PA, Smit AJ, Girbes AR, Journée, van Gilst WH, Hillege H, van Veldhuisen DJ, Wesseling H, Lie KI.

J Cardiovasc Pharmacol. 1995 Jan;25(1):105-12.

PMID:
7723338
28.

Inability to detect plasma etretinate and acitretin is a poor predictor of the absence of these teratogens in tissue after stopping acitretin treatment.

Sturkenboom MC, de Jong-Van Den Berg LT, van Voorst-Vader PC, Cornel MC, Stricker BH, Wesseling H.

Br J Clin Pharmacol. 1994 Sep;38(3):229-35.

29.

Late potentials, QTc prolongation, and prediction of arrhythmic events after myocardial infarction.

Tobé TJ, de Langen CD, Crijns HJ, Wiesfeld AC, van Gilst WH, Faber KG, Lie KI, Wesseling H.

Int J Cardiol. 1994 Sep;46(2):121-8.

PMID:
7814160
30.

Effect of metoprolol on atrial fibrillatory rate, atrioventricular nodal concealed conduction, and ventricular response during atrial fibrillation in pigs.

van den Berg MP, de Langen CD, Crijns HJ, Haaksma J, Bel KJ, Wesseling H, Lie KI.

J Cardiovasc Pharmacol. 1994 May;23(5):846-51.

PMID:
7521471
31.

Neurohumoral and hemodynamic effects of ibopamine in a rat model of chronic myocardial infarction and heart failure.

van Veldhuisen DJ, van Gilst WH, de Smet BJ, de Graeff PA, Scholtens E, Buikema H, Girbes AR, Wesseling H, Lie KI.

Cardiovasc Drugs Ther. 1994 Apr;8(2):245-50.

PMID:
7918137
32.

Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.

van Wijngaarden J, Smit AJ, de Graeff PA, van Gilst WH, van der Broek SA, van Veldhuisen DJ, Lie KI, Wesseling H.

J Cardiovasc Pharmacol. 1994 Feb;23(2):240-5.

PMID:
7511753
33.

Communicating a drug alert. A case study on acitretin in The Netherlands.

Sturkenboom MC, de Jong-van den Berg LT, Cornel MC, Stricker BH, Wesseling H.

Eur J Clin Pharmacol. 1994;47(2):125-32.

PMID:
7859798
34.

Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine.

Buikema H, van Gilst WH, van Veldhuisen DJ, de Smet BJ, Scholtens E, Lie KI, Wesseling H.

Cardiovasc Res. 1993 Dec;27(12):2118-24.

PMID:
8313417
35.

Comparative study of diltiazem and lisinopril in hypertension: similar improvements in diastolic function despite different effects on left ventricular mass and ambulatory blood pressure.

van Leeuwen JT, Smit AJ, May JF, ten Berge BS, Hamer HP, Havinga TK, Schuurman FH, van der Veur E, Lie KI, Wesseling H.

J Hypertens Suppl. 1993 Dec;11(5):S366-7. No abstract available.

PMID:
8158425
36.

Selective and time related activation of the cardiac renin-angiotensin system after experimental heart failure: relation to ventricular function and morphology.

Pinto YM, de Smet BG, van Gilst WH, Scholtens E, Monnink S, de Graeff PA, Wesseling H.

Cardiovasc Res. 1993 Nov;27(11):1933-8.

PMID:
8287399
37.

Characterization of hypertensive subjects who become normotensive during three months of office BP follow-up: comparison with subjects with sustained hypertension and normotensives, and follow-up after two years.

van Leeuwen JT, ten Berge BS, Hamer JP, Havinga TK, May JF, Smit AJ, Schuurman FH, van der Veur E, Lie KI, Wesseling H.

J Hum Hypertens. 1993 Oct;7(5):509-14.

PMID:
8263894
38.

Effects of streptokinase during acute myocardial infarction on the signal-averaged electrocardiogram and on the frequency of late arrhythmias.

Tobé TJ, de Langen CD, Crijns HJ, Wiesfeld AC, van Gilst WH, Faber KG, Lie KI, Wesseling H.

Am J Cardiol. 1993 Sep 15;72(9):647-51.

PMID:
8249838
39.

Drug expectations and drug choices of hospital physicians.

Denig P, Haaijer-Ruskamp FM, Wesseling H, Versluis A.

J Intern Med. 1993 Aug;234(2):155-63.

PMID:
8340738
40.

Towards understanding treatment preferences of hospital physicians.

Denig P, Haaijer-Ruskamp FM, Wesseling H, Versluis A.

Soc Sci Med. 1993 Apr;36(7):915-24.

PMID:
8480237
41.

Sustained atrial flutter around the tricuspid valve in pigs: differentiation of procainamide (class IA) from flecainide (class IC) and their rate-dependent effects.

Crijns HJ, de Langen CD, Grandjean JG, Bel KJ, Ebels T, Lie KI, Wesseling H.

J Cardiovasc Pharmacol. 1993 Mar;21(3):462-70.

PMID:
7681509
42.

[On which criteria are drug choices by hospital physicians based?].

Denig P, Haaijer-Ruskamp FM, Wesseling H, Versluis A.

Ned Tijdschr Geneeskd. 1993 Feb 27;137(9):448-51. Dutch. No abstract available.

PMID:
8446212
43.

Drug use in pregnancy: a comparative appraisal of data collecting methods.

de Jong-van den Berg LT, Waardenburg CM, Haaijer-Ruskamp FM, Dukes MN, Wesseling H.

Eur J Clin Pharmacol. 1993;45(1):9-14.

PMID:
8405037
44.

Differences in vasomotor control between human gastroepiploic and left internal mammary artery.

Buikema H, Grandjean JG, van den Broek S, van Gilst WH, Lie KI, Wesseling H.

Circulation. 1992 Nov;86(5 Suppl):II205-9.

PMID:
1424001
45.

Late potentials in a porcine model of anterior wall myocardial infarction and their relation to inducible ventricular tachycardia.

Tobé TJ, de Langen CD, Mook PH, Tio RA, Bel KJ, de Graeff PA, van Gilst WH, Wesseling H.

Pacing Clin Electrophysiol. 1992 Nov;15(11 Pt 1):1760-71.

PMID:
1279544
46.

Captopril modifies the response of infarcted rat hearts to isoprenaline stimulation.

van Wijngaarden J, Monnink SH, Bartels H, van Gilst WH, de Graeff PA, de Langen CD, Wesseling H.

J Cardiovasc Pharmacol. 1992 May;19(5):741-7.

PMID:
1381772
47.

The angiotensin converting enzyme inhibitor perindopril improves survival after experimental myocardial infarction in pigs.

Tobé TJ, de Langen CD, Weersink EG, van Wijngaarden J, Bel KJ, de Graeff PA, van Gilst WH, Wesseling H.

J Cardiovasc Pharmacol. 1992 May;19(5):732-40.

PMID:
1381771
48.

Handling of risk-bearing drugs during pregnancy. Do we choose less risky alternatives?

De Jong-Van den Berg LT, Van den Berg PB, Haaijer-Ruskamp FM, Dukes MN, Wesseling H.

Pharm Weekbl Sci. 1992 Apr 24;14(2):38-45.

PMID:
1528709
49.

Acitretin (Neotigason). A review of pharmacokinetics and teratogenicity and hypothesis on metabolic pathways.

Bouvy ML, Sturkenboom MC, Cornel MC, De Jong-Van den Berg LT, Stricker BH, Wesseling H.

Pharm Weekbl Sci. 1992 Apr 24;14(2):33-7. Review.

PMID:
1388261
50.

[Dry mouth; possible cause--pharmaceuticals].

Vissink A, van Nieuw Amerongen A, Wesseling H, 's-Gravenmade EJ.

Ned Tijdschr Tandheelkd. 1992 Mar;99(3):103-12. Review. Dutch.

PMID:
11819982

Supplemental Content

Loading ...
Support Center